vectashield hardset mounting medium Search Results


96
Vector Laboratories vectashield hardset antifade mounting medium with dapi
Vectashield Hardset Antifade Mounting Medium With Dapi, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vectashield hardset antifade mounting medium with dapi/product/Vector Laboratories
Average 96 stars, based on 1 article reviews
vectashield hardset antifade mounting medium with dapi - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

96
Vector Laboratories vectashield
Vectashield, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vectashield/product/Vector Laboratories
Average 96 stars, based on 1 article reviews
vectashield - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

93
Vector Laboratories phalloidin
CSPG4 blockade reduces TcdB‐induced NFκB nuclear translocation and IL‐6 gene expression. (A) Representative photomicrographs of NFκB (green) immunostaining, <t>phalloidin</t> (red) as a cytoplasm staining, and DAPI (blue) as a nuclear staining in enteric glia cells exposed to TcdA (50 ng/mL) or TcdB (1 ng/mL) at 18 h incubation in the presence of isotype control or anti‐CSPG4 antibodies (0.001 μg/mL). Scale bars: 50 μm. (B) Percentage of enteric glia cells ( n = 5, mean ± SEM) with positive nuclear NFκBp65 staining at 18 h of incubation with TcdA and TcdB in the presence of isotype control or anti‐CSPG4 antibodies. (C) IL‐6 gene expression (mean ± SEM) by qPCR in enteric glial cells challenged with TcdA or TcdB at 18 h of incubation in the presence of isotype control or anti‐CSPG4 antibodies (0.001 μg/mL). (B‐C) One‐way ANOVA followed by the Tukey test.
Phalloidin, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phalloidin/product/Vector Laboratories
Average 93 stars, based on 1 article reviews
phalloidin - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

92
Novus Biologicals vectashield hard set mounting medium
CSPG4 blockade reduces TcdB‐induced NFκB nuclear translocation and IL‐6 gene expression. (A) Representative photomicrographs of NFκB (green) immunostaining, <t>phalloidin</t> (red) as a cytoplasm staining, and DAPI (blue) as a nuclear staining in enteric glia cells exposed to TcdA (50 ng/mL) or TcdB (1 ng/mL) at 18 h incubation in the presence of isotype control or anti‐CSPG4 antibodies (0.001 μg/mL). Scale bars: 50 μm. (B) Percentage of enteric glia cells ( n = 5, mean ± SEM) with positive nuclear NFκBp65 staining at 18 h of incubation with TcdA and TcdB in the presence of isotype control or anti‐CSPG4 antibodies. (C) IL‐6 gene expression (mean ± SEM) by qPCR in enteric glial cells challenged with TcdA or TcdB at 18 h of incubation in the presence of isotype control or anti‐CSPG4 antibodies (0.001 μg/mL). (B‐C) One‐way ANOVA followed by the Tukey test.
Vectashield Hard Set Mounting Medium, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vectashield hard set mounting medium/product/Novus Biologicals
Average 92 stars, based on 1 article reviews
vectashield hard set mounting medium - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

90
Biozol Diagnostica Vertrieb GmbH vectashield hardset mounting medium with 4 0, 6-diamino-2-phenylindole (dapi) vec-h-1500
CSPG4 blockade reduces TcdB‐induced NFκB nuclear translocation and IL‐6 gene expression. (A) Representative photomicrographs of NFκB (green) immunostaining, <t>phalloidin</t> (red) as a cytoplasm staining, and DAPI (blue) as a nuclear staining in enteric glia cells exposed to TcdA (50 ng/mL) or TcdB (1 ng/mL) at 18 h incubation in the presence of isotype control or anti‐CSPG4 antibodies (0.001 μg/mL). Scale bars: 50 μm. (B) Percentage of enteric glia cells ( n = 5, mean ± SEM) with positive nuclear NFκBp65 staining at 18 h of incubation with TcdA and TcdB in the presence of isotype control or anti‐CSPG4 antibodies. (C) IL‐6 gene expression (mean ± SEM) by qPCR in enteric glial cells challenged with TcdA or TcdB at 18 h of incubation in the presence of isotype control or anti‐CSPG4 antibodies (0.001 μg/mL). (B‐C) One‐way ANOVA followed by the Tukey test.
Vectashield Hardset Mounting Medium With 4 0, 6 Diamino 2 Phenylindole (Dapi) Vec H 1500, supplied by Biozol Diagnostica Vertrieb GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vectashield hardset mounting medium with 4 0, 6-diamino-2-phenylindole (dapi) vec-h-1500/product/Biozol Diagnostica Vertrieb GmbH
Average 90 stars, based on 1 article reviews
vectashield hardset mounting medium with 4 0, 6-diamino-2-phenylindole (dapi) vec-h-1500 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Beijing Solarbio Science vectashield hardset mounting medium with/without 4′,6-diamidino-2-phenylindole (dapi)
CSPG4 blockade reduces TcdB‐induced NFκB nuclear translocation and IL‐6 gene expression. (A) Representative photomicrographs of NFκB (green) immunostaining, <t>phalloidin</t> (red) as a cytoplasm staining, and DAPI (blue) as a nuclear staining in enteric glia cells exposed to TcdA (50 ng/mL) or TcdB (1 ng/mL) at 18 h incubation in the presence of isotype control or anti‐CSPG4 antibodies (0.001 μg/mL). Scale bars: 50 μm. (B) Percentage of enteric glia cells ( n = 5, mean ± SEM) with positive nuclear NFκBp65 staining at 18 h of incubation with TcdA and TcdB in the presence of isotype control or anti‐CSPG4 antibodies. (C) IL‐6 gene expression (mean ± SEM) by qPCR in enteric glial cells challenged with TcdA or TcdB at 18 h of incubation in the presence of isotype control or anti‐CSPG4 antibodies (0.001 μg/mL). (B‐C) One‐way ANOVA followed by the Tukey test.
Vectashield Hardset Mounting Medium With/Without 4′,6 Diamidino 2 Phenylindole (Dapi), supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vectashield hardset mounting medium with/without 4′,6-diamidino-2-phenylindole (dapi)/product/Beijing Solarbio Science
Average 90 stars, based on 1 article reviews
vectashield hardset mounting medium with/without 4′,6-diamidino-2-phenylindole (dapi) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Zotal Ltd vectashield hardset mounting medium
CSPG4 blockade reduces TcdB‐induced NFκB nuclear translocation and IL‐6 gene expression. (A) Representative photomicrographs of NFκB (green) immunostaining, <t>phalloidin</t> (red) as a cytoplasm staining, and DAPI (blue) as a nuclear staining in enteric glia cells exposed to TcdA (50 ng/mL) or TcdB (1 ng/mL) at 18 h incubation in the presence of isotype control or anti‐CSPG4 antibodies (0.001 μg/mL). Scale bars: 50 μm. (B) Percentage of enteric glia cells ( n = 5, mean ± SEM) with positive nuclear NFκBp65 staining at 18 h of incubation with TcdA and TcdB in the presence of isotype control or anti‐CSPG4 antibodies. (C) IL‐6 gene expression (mean ± SEM) by qPCR in enteric glial cells challenged with TcdA or TcdB at 18 h of incubation in the presence of isotype control or anti‐CSPG4 antibodies (0.001 μg/mL). (B‐C) One‐way ANOVA followed by the Tukey test.
Vectashield Hardset Mounting Medium, supplied by Zotal Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vectashield hardset mounting medium/product/Zotal Ltd
Average 90 stars, based on 1 article reviews
vectashield hardset mounting medium - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Merck KGaA vectashield® hardset tm antifade mounting medium with dapi
Experimental setup and essential equipment for in utero electroporation (A) Image of the whole setup for in utero electroporation. (B) Images of the electroporator to deliver electrical stimulation to pups (upper) and the micro injector to inject the plasmids (lower). (C) Images of surgical implements and a glass pipette which contains the diluted solution including plasmids for in utero electroporation. (D) Scheme of the in utero electroporation. The plasmid is injected into the fetal lateral ventricle and electrical stimulation is delivered via the forceps-shaped bipolar electrode. The electroporation is performed on 6–8 embryos in a single operation. (E) Inject the solution containing the plasmid into one side of the lateral ventricles on each embryo. The injection site of the plasmid should be 0.75–1.0 mm anterior from lambda and 0.5 mm lateral from the sagittal suture. (F) The positions of the electrode to target the mPFC. Note that the negative pole is positioned over the injected hemisphere while the positive one is positioned on the contralateral side. The two electrodes are slightly angled rostrocaudally and vertically as seen. (G–I) Low (G) and high (H) magnification Images of injection of the plasmids and image of delivering electrical stimulation through a forceps-shape electrode (I) during in utero electroporation. (J) Image of the mPFC from an electroporated mouse. The green signal shows GFP and the blue signal represents <t>DAPI</t> staining. Scale, 1mm. (K) High-magnification image of the electroporated mPFC expressing GFP. Scale, 50 μm. See also .
Vectashield® Hardset Tm Antifade Mounting Medium With Dapi, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vectashield® hardset tm antifade mounting medium with dapi/product/Merck KGaA
Average 90 stars, based on 1 article reviews
vectashield® hardset tm antifade mounting medium with dapi - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
BioLynx Inc vectashield hardset mounting medium vecth1400
Experimental setup and essential equipment for in utero electroporation (A) Image of the whole setup for in utero electroporation. (B) Images of the electroporator to deliver electrical stimulation to pups (upper) and the micro injector to inject the plasmids (lower). (C) Images of surgical implements and a glass pipette which contains the diluted solution including plasmids for in utero electroporation. (D) Scheme of the in utero electroporation. The plasmid is injected into the fetal lateral ventricle and electrical stimulation is delivered via the forceps-shaped bipolar electrode. The electroporation is performed on 6–8 embryos in a single operation. (E) Inject the solution containing the plasmid into one side of the lateral ventricles on each embryo. The injection site of the plasmid should be 0.75–1.0 mm anterior from lambda and 0.5 mm lateral from the sagittal suture. (F) The positions of the electrode to target the mPFC. Note that the negative pole is positioned over the injected hemisphere while the positive one is positioned on the contralateral side. The two electrodes are slightly angled rostrocaudally and vertically as seen. (G–I) Low (G) and high (H) magnification Images of injection of the plasmids and image of delivering electrical stimulation through a forceps-shape electrode (I) during in utero electroporation. (J) Image of the mPFC from an electroporated mouse. The green signal shows GFP and the blue signal represents <t>DAPI</t> staining. Scale, 1mm. (K) High-magnification image of the electroporated mPFC expressing GFP. Scale, 50 μm. See also .
Vectashield Hardset Mounting Medium Vecth1400, supplied by BioLynx Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vectashield hardset mounting medium vecth1400/product/BioLynx Inc
Average 90 stars, based on 1 article reviews
vectashield hardset mounting medium vecth1400 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

98
Vector Laboratories 4 6 diamidino 2 phenylindole
Experimental setup and essential equipment for in utero electroporation (A) Image of the whole setup for in utero electroporation. (B) Images of the electroporator to deliver electrical stimulation to pups (upper) and the micro injector to inject the plasmids (lower). (C) Images of surgical implements and a glass pipette which contains the diluted solution including plasmids for in utero electroporation. (D) Scheme of the in utero electroporation. The plasmid is injected into the fetal lateral ventricle and electrical stimulation is delivered via the forceps-shaped bipolar electrode. The electroporation is performed on 6–8 embryos in a single operation. (E) Inject the solution containing the plasmid into one side of the lateral ventricles on each embryo. The injection site of the plasmid should be 0.75–1.0 mm anterior from lambda and 0.5 mm lateral from the sagittal suture. (F) The positions of the electrode to target the mPFC. Note that the negative pole is positioned over the injected hemisphere while the positive one is positioned on the contralateral side. The two electrodes are slightly angled rostrocaudally and vertically as seen. (G–I) Low (G) and high (H) magnification Images of injection of the plasmids and image of delivering electrical stimulation through a forceps-shape electrode (I) during in utero electroporation. (J) Image of the mPFC from an electroporated mouse. The green signal shows GFP and the blue signal represents <t>DAPI</t> staining. Scale, 1mm. (K) High-magnification image of the electroporated mPFC expressing GFP. Scale, 50 μm. See also .
4 6 Diamidino 2 Phenylindole, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/4 6 diamidino 2 phenylindole/product/Vector Laboratories
Average 98 stars, based on 1 article reviews
4 6 diamidino 2 phenylindole - by Bioz Stars, 2026-05
98/100 stars
  Buy from Supplier

Image Search Results


CSPG4 blockade reduces TcdB‐induced NFκB nuclear translocation and IL‐6 gene expression. (A) Representative photomicrographs of NFκB (green) immunostaining, phalloidin (red) as a cytoplasm staining, and DAPI (blue) as a nuclear staining in enteric glia cells exposed to TcdA (50 ng/mL) or TcdB (1 ng/mL) at 18 h incubation in the presence of isotype control or anti‐CSPG4 antibodies (0.001 μg/mL). Scale bars: 50 μm. (B) Percentage of enteric glia cells ( n = 5, mean ± SEM) with positive nuclear NFκBp65 staining at 18 h of incubation with TcdA and TcdB in the presence of isotype control or anti‐CSPG4 antibodies. (C) IL‐6 gene expression (mean ± SEM) by qPCR in enteric glial cells challenged with TcdA or TcdB at 18 h of incubation in the presence of isotype control or anti‐CSPG4 antibodies (0.001 μg/mL). (B‐C) One‐way ANOVA followed by the Tukey test.

Journal: The FASEB Journal

Article Title: CSPG4 Mediates Inflammatory, Cell Death, and Senescence Responses in Enteric Glia Exposed to Clostridioides difficile Toxins

doi: 10.1096/fj.202600333R

Figure Lengend Snippet: CSPG4 blockade reduces TcdB‐induced NFκB nuclear translocation and IL‐6 gene expression. (A) Representative photomicrographs of NFκB (green) immunostaining, phalloidin (red) as a cytoplasm staining, and DAPI (blue) as a nuclear staining in enteric glia cells exposed to TcdA (50 ng/mL) or TcdB (1 ng/mL) at 18 h incubation in the presence of isotype control or anti‐CSPG4 antibodies (0.001 μg/mL). Scale bars: 50 μm. (B) Percentage of enteric glia cells ( n = 5, mean ± SEM) with positive nuclear NFκBp65 staining at 18 h of incubation with TcdA and TcdB in the presence of isotype control or anti‐CSPG4 antibodies. (C) IL‐6 gene expression (mean ± SEM) by qPCR in enteric glial cells challenged with TcdA or TcdB at 18 h of incubation in the presence of isotype control or anti‐CSPG4 antibodies (0.001 μg/mL). (B‐C) One‐way ANOVA followed by the Tukey test.

Article Snippet: Slides were mounted using antifade mounting medium containing phalloidin (Vector Labs, H1600) to visualize the actin cytoskeleton.

Techniques: Translocation Assay, Gene Expression, Immunostaining, Staining, Incubation, Control

CSPG4 blockade reduces TcdB‐induced pSTAT3 nuclear translocation in enteric glial cells. (A) Representative photomicrographs of pSTAT3 (green) immunostaining, phalloidin (red) as a cytoplasm staining, and DAPI (blue) as a nuclear staining in enteric glial cells exposed to TcdA (50 ng/mL) or TcdB (1 ng/mL) at 18 h incubation in the presence of isotype control or anti‐CSPG4 antibodies (0.001 μg/mL). Scale bars: 50 μm. (B) Percentage of enteric glial cells ( n = 5, mean ± SEM) with positive nuclear pSTAT3 staining at 18 h of incubation with TcdA and TcdB in the presence of isotype control or anti‐CSPG4 antibodies (0.001 μg/mL). One‐way ANOVA followed by the Tukey test.

Journal: The FASEB Journal

Article Title: CSPG4 Mediates Inflammatory, Cell Death, and Senescence Responses in Enteric Glia Exposed to Clostridioides difficile Toxins

doi: 10.1096/fj.202600333R

Figure Lengend Snippet: CSPG4 blockade reduces TcdB‐induced pSTAT3 nuclear translocation in enteric glial cells. (A) Representative photomicrographs of pSTAT3 (green) immunostaining, phalloidin (red) as a cytoplasm staining, and DAPI (blue) as a nuclear staining in enteric glial cells exposed to TcdA (50 ng/mL) or TcdB (1 ng/mL) at 18 h incubation in the presence of isotype control or anti‐CSPG4 antibodies (0.001 μg/mL). Scale bars: 50 μm. (B) Percentage of enteric glial cells ( n = 5, mean ± SEM) with positive nuclear pSTAT3 staining at 18 h of incubation with TcdA and TcdB in the presence of isotype control or anti‐CSPG4 antibodies (0.001 μg/mL). One‐way ANOVA followed by the Tukey test.

Article Snippet: Slides were mounted using antifade mounting medium containing phalloidin (Vector Labs, H1600) to visualize the actin cytoskeleton.

Techniques: Translocation Assay, Immunostaining, Staining, Incubation, Control

Experimental setup and essential equipment for in utero electroporation (A) Image of the whole setup for in utero electroporation. (B) Images of the electroporator to deliver electrical stimulation to pups (upper) and the micro injector to inject the plasmids (lower). (C) Images of surgical implements and a glass pipette which contains the diluted solution including plasmids for in utero electroporation. (D) Scheme of the in utero electroporation. The plasmid is injected into the fetal lateral ventricle and electrical stimulation is delivered via the forceps-shaped bipolar electrode. The electroporation is performed on 6–8 embryos in a single operation. (E) Inject the solution containing the plasmid into one side of the lateral ventricles on each embryo. The injection site of the plasmid should be 0.75–1.0 mm anterior from lambda and 0.5 mm lateral from the sagittal suture. (F) The positions of the electrode to target the mPFC. Note that the negative pole is positioned over the injected hemisphere while the positive one is positioned on the contralateral side. The two electrodes are slightly angled rostrocaudally and vertically as seen. (G–I) Low (G) and high (H) magnification Images of injection of the plasmids and image of delivering electrical stimulation through a forceps-shape electrode (I) during in utero electroporation. (J) Image of the mPFC from an electroporated mouse. The green signal shows GFP and the blue signal represents DAPI staining. Scale, 1mm. (K) High-magnification image of the electroporated mPFC expressing GFP. Scale, 50 μm. See also .

Journal: STAR Protocols

Article Title: Combining electrophysiology and optogenetics for functional screening of pyramidal neurons in the mouse prefrontal cortex

doi: 10.1016/j.xpro.2021.100469

Figure Lengend Snippet: Experimental setup and essential equipment for in utero electroporation (A) Image of the whole setup for in utero electroporation. (B) Images of the electroporator to deliver electrical stimulation to pups (upper) and the micro injector to inject the plasmids (lower). (C) Images of surgical implements and a glass pipette which contains the diluted solution including plasmids for in utero electroporation. (D) Scheme of the in utero electroporation. The plasmid is injected into the fetal lateral ventricle and electrical stimulation is delivered via the forceps-shaped bipolar electrode. The electroporation is performed on 6–8 embryos in a single operation. (E) Inject the solution containing the plasmid into one side of the lateral ventricles on each embryo. The injection site of the plasmid should be 0.75–1.0 mm anterior from lambda and 0.5 mm lateral from the sagittal suture. (F) The positions of the electrode to target the mPFC. Note that the negative pole is positioned over the injected hemisphere while the positive one is positioned on the contralateral side. The two electrodes are slightly angled rostrocaudally and vertically as seen. (G–I) Low (G) and high (H) magnification Images of injection of the plasmids and image of delivering electrical stimulation through a forceps-shape electrode (I) during in utero electroporation. (J) Image of the mPFC from an electroporated mouse. The green signal shows GFP and the blue signal represents DAPI staining. Scale, 1mm. (K) High-magnification image of the electroporated mPFC expressing GFP. Scale, 50 μm. See also .

Article Snippet: VECTASHIELD® HardSet TM Antifade Mounting Medium with DAPI , Merck Millipore , CAT: # H-1500-10.

Techniques: In Utero, Electroporation, Transferring, Plasmid Preparation, Injection, Staining, Expressing

Journal: STAR Protocols

Article Title: Combining electrophysiology and optogenetics for functional screening of pyramidal neurons in the mouse prefrontal cortex

doi: 10.1016/j.xpro.2021.100469

Figure Lengend Snippet:

Article Snippet: VECTASHIELD® HardSet TM Antifade Mounting Medium with DAPI , Merck Millipore , CAT: # H-1500-10.

Techniques: Recombinant, Mutagenesis, Transfection, Blocking Assay, Expressing, Plasmid Preparation, DNA Purification, cDNA Synthesis, Ligation, Software, In Utero, Electroporation, Microscopy